Mount Sinai Researchers Discover New Target for Vaccine Development in Abundant Immune Cells
July 24, 2012
Certain White Blood Cells May Be Useful in Vaccinating Against Blood-borne Infections and HIV.
Mount Sinai Researchers Present Studies On Treatment Trends, Myeloma Vaccine, and Predictive Models at Cancer Meeting
May 17, 2012
Access to care, vaccine, treatment trends among landmark research at the 2012 American Society of Clinical Oncology meeting.
Young Immunology Researchers Receive Prestigious Grant For Outstanding Discoveries
June 16, 2011
Benjamin tenOever, PhD, and Julie Magarian Blander, PhD, each received a grant from the Burroughs Wellcome Fund for their pioneering work in the study of infectious diseases
Study Finds That Those with Hard-to-Treat Forms of Hepatitis C Are Half As Likely to Begin Treatment
November 9, 2009
Mount Sinai researchers conclude that patients with hard-to-treat forms of hepatitis C are less likely to seek treatment than those with less difficult-to-treat versions of the disease.